These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23162891)

  • 1. [The molecular physiological and genetic mechanisms underlying the superb efficacy of quinolones].
    Long QX; He Y; Xie JP
    Yao Xue Xue Bao; 2012 Aug; 47(8):969-77. PubMed ID: 23162891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial action of quinolones: from target to network.
    Cheng G; Hao H; Dai M; Liu Z; Yuan Z
    Eur J Med Chem; 2013 Aug; 66():555-62. PubMed ID: 23528390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lethal fragmentation of bacterial chromosomes mediated by DNA gyrase and quinolones.
    Malik M; Zhao X; Drlica K
    Mol Microbiol; 2006 Aug; 61(3):810-25. PubMed ID: 16803589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection.
    Ruiz J
    J Antimicrob Chemother; 2003 May; 51(5):1109-17. PubMed ID: 12697644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of quinolone action and microbial response.
    Hawkey PM
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():29-35. PubMed ID: 12702701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of (3S)-amino-(4R)-ethylpiperidinyl quinolones as potent antibacterial agents with a broad spectrum of activity and activity against resistant pathogens.
    Hu XE; Kim NK; Gray JL; Almstead JI; Seibel WL; Ledoussal B
    J Med Chem; 2003 Aug; 46(17):3655-61. PubMed ID: 12904069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-methicillin-resistant Staphylococcus aureus quinolone WCK 771 has potent activity against sequentially selected mutants, has a narrow mutant selection window against quinolone-resistant Staphylococcus aureus, and preferentially targets DNA gyrase.
    Bhagwat SS; Mundkur LA; Gupte SV; Patel MV; Khorakiwala HF
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3568-79. PubMed ID: 16940059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolone uptake by bacteria and bacterial killing.
    Diver JM
    Rev Infect Dis; 1989; 11 Suppl 5():S941-6. PubMed ID: 2549609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase inhibition, nucleolytic and electrolytic contribution on DNA binding activity exerted by biological active analogue of coordination compounds.
    Patel MN; Bhatt BS; Dosi PA
    Appl Biochem Biotechnol; 2012 Apr; 166(8):1949-68. PubMed ID: 22391694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in bacterial topoisomerase inhibitors.
    Bradbury BJ; Pucci MJ
    Curr Opin Pharmacol; 2008 Oct; 8(5):574-81. PubMed ID: 18555745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resistance acquisition via the bacterial SOS response: the inducive role of antibiotics].
    Da Re S; Ploy MC
    Med Sci (Paris); 2012 Feb; 28(2):179-84. PubMed ID: 22377306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usual and unusual antibacterial effects of quinolones.
    Furet YX; Pechère JC
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():7-15. PubMed ID: 2175306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial death from treatment with fluoroquinolones and other lethal stressors.
    Drlica K; Zhao X
    Expert Rev Anti Infect Ther; 2021 May; 19(5):601-618. PubMed ID: 33081547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-targeting properties of the 3-aminopyrrolidyl quinolones, DC-159a and sitafloxacin, against DNA gyrase and topoisomerase IV: contribution to reducing in vitro emergence of quinolone-resistant Streptococcus pneumoniae.
    Okumura R; Hirata T; Onodera Y; Hoshino K; Otani T; Yamamoto T
    J Antimicrob Chemother; 2008 Jul; 62(1):98-104. PubMed ID: 18390884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial property of pyrrolopyrano quinolinones and pyrroloquinolines.
    Jayagobi M; Raghunathan R; Sainath S; Raghunathan M
    Eur J Med Chem; 2011 Jun; 46(6):2075-82. PubMed ID: 21444131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bacterial type II topoisomerases as targets for antibacterial drugs].
    Pietrusiński M; Staczek P
    Postepy Biochem; 2006; 52(3):271-82. PubMed ID: 17201062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
    Chen CR; Malik M; Snyder M; Drlica K
    J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolones: Mechanism, Lethality and Their Contributions to Antibiotic Resistance.
    Bush NG; Diez-Santos I; Abbott LR; Maxwell A
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33271787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.